Departments of1Neurosurgery.
4Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; and.
J Neurosurg. 2018 Dec 14;131(6):1974-1984. doi: 10.3171/2018.7.JNS181642. Print 2019 Dec 1.
Intraoperative molecular imaging with tumor-targeted fluorescent dyes can enhance resection rates. In contrast to visible-light fluorophores (e.g., 5-aminolevulinic-acid), near-infrared (NIR) fluorophores have increased photon tissue penetration and less contamination from tissue autofluorescence. The second-window ICG (SWIG) technique relies on passive accumulation of indocyanine green (ICG) in neoplastic tissues. OTL38, conversely, targets folate receptor overexpression in nonfunctioning pituitary adenomas. In this study, we compare the properties of these 2 modalities for NIR imaging of pituitary adenomas to better understand the potential for NIR imaging in neurosurgery.
A total of 39 patients with pituitary adenomas were enrolled between June 2015 and January 2018 in 2, sequential, IRB-approved studies. Sixteen patients received systemic ICG infusions 24 hours prior to surgery, and another 23 patients received OTL38 infusions 2-3 hours prior to surgery. NIR fluorescence signal-to-background ratio (SBR) was recorded during and after resection. Immunohistochemistry was performed on the 23 adenomas resected from patients who received OTL38 to assess expression of folate receptor-alpha (FRα).
All 16 adenomas operated on after ICG administration demonstrated strong NIR fluorescence (mean SBR 4.1 ± 0.69 [SD]). There was no statistically significant difference between the 9 functioning and 7 nonfunctioning adenomas (p = 0.9). After administration of OTL38, the mean SBR was 1.7 ± 0.47 for functioning adenomas, 2.6 ± 0.91 for all nonfunctioning adenomas, and 3.2 ± 0.53 for the subset of FRα-overexpressing adenomas. Tissue identification with white light alone for all adenomas demonstrated 88% sensitivity and 90% specificity. SWIG demonstrated 100% sensitivity but only 29% specificity for both functioning and nonfunctioning adenomas. OTL38 was 75% sensitive and 100% specific for all nonfunctioning adenomas, but when assessment was limited to the 9 FRα-overexpressing adenomas, the sensitivity and specificity of OTL38 were both 100%.
Intraoperative imaging with NIR fluorophores demonstrates highly sensitive detection of pituitary adenomas. OTL38, a folate-receptor-targeted fluorophore, is highly specific for nonfunctioning adenomas but has no utility in functioning adenomas. SWIG, which relies on passive diffusion into neoplastic tissue, is applicable to both functioning and nonfunctioning pituitary adenomas, but it is less specific than targeted fluorophores. Thus, targeted and nontargeted NIR fluorophores play important, yet distinct, roles in intraoperative imaging. Selectively and intelligently using either agent has the potential to greatly improve resection rates and outcomes for patients with intracranial tumors.
术中应用肿瘤靶向荧光染料进行分子成像可以提高切除率。与可见光荧光团(如 5-氨基酮戊酸)相比,近红外(NIR)荧光团具有增加的光子组织穿透性和较少的组织自发荧光污染。第二窗口吲哚菁绿(ICG)技术依赖于吲哚菁绿(ICG)在肿瘤组织中的被动积累。相反,OTL38 靶向无功能垂体腺瘤中的叶酸受体过表达。在这项研究中,我们比较了这两种模态用于垂体腺瘤的近红外成像的特性,以更好地了解近红外成像在神经外科中的潜力。
2015 年 6 月至 2018 年 1 月,共有 39 例垂体腺瘤患者连续入组了 2 项经 IRB 批准的研究。16 例患者在术前 24 小时接受全身 ICG 输注,另有 23 例患者在术前 2-3 小时接受 OTL38 输注。在切除过程中和切除后记录近红外荧光信号与背景的比值(SBR)。对接受 OTL38 治疗的 23 例腺瘤患者切除的腺瘤进行免疫组织化学染色,以评估叶酸受体-α(FRα)的表达。
所有在 ICG 给药后进行手术的 16 例腺瘤均表现出强烈的近红外荧光(平均 SBR 为 4.1 ± 0.69 [SD])。功能腺瘤和无功能腺瘤之间没有统计学上的显著差异(p = 0.9)。在 OTL38 给药后,功能腺瘤的平均 SBR 为 1.7 ± 0.47,所有无功能腺瘤的平均 SBR 为 2.6 ± 0.91,FRα 过表达腺瘤的平均 SBR 为 3.2 ± 0.53。所有腺瘤仅用白光进行组织识别的敏感性为 88%,特异性为 90%。SWIG 对功能腺瘤和无功能腺瘤的敏感性均为 100%,但特异性仅为 29%。OTL38 对所有无功能腺瘤的敏感性为 75%,特异性为 100%,但当评估仅限于 9 例 FRα 过表达腺瘤时,OTL38 的敏感性和特异性均为 100%。
近红外荧光团的术中成像显示出对垂体腺瘤的高度敏感检测。OTL38 是一种叶酸受体靶向荧光团,对无功能腺瘤具有高度特异性,但对功能腺瘤没有作用。SWIG 依赖于被动扩散进入肿瘤组织,适用于功能腺瘤和无功能腺瘤,但特异性低于靶向荧光团。因此,靶向和非靶向近红外荧光团在术中成像中发挥着重要而独特的作用。有选择性地和智能地使用这两种试剂有可能极大地提高颅内肿瘤患者的切除率和治疗效果。